Latest News about pharmaceuticals
Recent news which mentions pharmaceuticals
   Novo Nordisk says copycat compounders are hurting Wegovy sales, may take legal action
   
  
  March 27, 2025
  From CNBC.com News
 
   Crinetics Pharmaceuticals Analyst Sees Around 70% Upside For Stock, Cites More Investor Interest In Endocrinology
   
  
  
  March 25, 2025
  From Benzinga
 
   Eli Lilly will soon release key data on its weight loss pill. Here's why it could be a game-changer
   
  
  March 24, 2025
  From CNBC.com News
 
   Novo Nordisk's next-gen obesity drug CagriSema had investors excited. Now they're not so sure
   
  
  March 24, 2025
  From CNBC.com News
 From CNBC.com News
 
   Zepbound copycats remain online despite FDA ban
   
  
  March 21, 2025
  From CNBC.com News
 
   Black Diamond Therapeutics Inks Licensing Pact With French Pharma Firm Servier For Its Early-Stage Cancer Drug Worth Over $700 Million
   
  
  
  March 19, 2025
  From Benzinga
 
   Clinic uses 'party drug' to treat depression
   
  
  March 18, 2025
  From Business Journals
 
   What's Going On With Arcutis Biotherapeutics Stock Monday?
   
  
  
  March 17, 2025
  From Benzinga
 
   White House pulls Trump’s nomination for CDC director
   
  
  March 13, 2025
  From CNBC.com News
 From CNBC.com News
 
   Novo Nordisk shares fall 5.5% after latest trial results for its next-generation weight loss drug
   
  
  March 10, 2025
  From CNBC.com News
 From CNBC.com News
 
   Vertex Newly Approved Pain Treatment Lands Higher Cost Tier 3 Placement In UnitedHealth's Optum Rx Formularies
   
  
  
  March 07, 2025
  From Benzinga
 From CNBC.com News
 From CNBC.com News
 
   Novo Nordisk offers Wegovy for less than half the price through new direct-to-consumer pharmacy
   
  
  March 05, 2025
  From CNBC.com News
 From Benzinga
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.